Cargando…
The potential role of lactulose pharmacotherapy in the treatment and prevention of diabetes
The non-absorbable disaccharide lactulose is mostly used in the treatment of various gastrointestinal disorders such as chronic constipation and hepatic encephalopathy. The mechanism of action of lactulose remains unclear, but it elicits more than osmotic laxative effects. As a prebiotic, lactulose...
Autores principales: | Chu, Natural, Ling, James, Jie, He, Leung, Kathy, Poon, Emily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519995/ https://www.ncbi.nlm.nih.gov/pubmed/36187096 http://dx.doi.org/10.3389/fendo.2022.956203 |
Ejemplares similares
-
Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes
por: Chu, Natural, et al.
Publicado: (2022) -
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
por: Tan, Qiming, et al.
Publicado: (2022) -
Emerging Trend in the Pharmacotherapy of Osteoarthritis
por: Zhang, Wei, et al.
Publicado: (2019) -
Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults
por: Bensignor, Megan O., et al.
Publicado: (2022) -
Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses
por: Deng, Jiawen, et al.
Publicado: (2020)